Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation

Steininger, J.; Buszello, C.; Oertel, R.; Meinhardt, M.; Schmid, S.; Engellandt, K.; Herold, S.; Stasik, S.; Ebrahimi, A.; Renner, B.; Thiede, C.; Eyüpoglu, I.Y.; Schackert, G.; Beissert, S.; Meier, F.; Radke, J.; Westphal, D.; Juratli, T. A.

doi:10.1186/s40478-024-01834-8

Acta Neuropathologica Communications

Article metrics
Last updated: Tue, 20 May 2025 13:21:42 Z

Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation

Access & Citations

1567

Article Accesses
1

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 2051-5960

Contact us

General enquiries: journalsubmissions@springernature.com